The path to treating multiple-etiology dementia: Combining vascular risk control and disease-modifying neurodegenerative therapies
An integrated research roadmap for MED is proposed that prioritizes biomarker-enriched cohorts, combination vascular and neurodegenerative therapies, and pragmatic trials, and offers the most plausible strategy to reduce the growing global burden of MED.